{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:46:03Z","timestamp":1789868763713,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jconrel.2006.10.012","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T05:56:53Z","timestamp":1161151013000},"page":"28-39","source":"Crossref","is-referenced-by-count":83,"title":["Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer\u2013Dox\u2013AGM in breast cancer cells"],"prefix":"10.1016","volume":"117","author":[{"given":"Francesca","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwyn T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2006.10.012_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2006.10.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/12_024","article-title":"Polymer therapeutics for cancer: current status and future challenges","volume":"193","author":"Satchi-Fainaro","year":"2006","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/j.jconrel.2006.10.012_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tibtech.2005.11.006","article-title":"Polymer-based nanomedicines: novel treatments for cancer","volume":"24","author":"Vicent","year":"2006","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrc1958","article-title":"Polymer\u2013drug conjugates as anticancer nanomedicines","volume":"6","author":"Duncan","year":"2006","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.jconrel.2006.10.012_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00001813-200503000-00003","article-title":"Paclitaxel poliglumex (XYOTAX; CT-2103) [XYOTAX\u2122]: an intracellularly targeted taxane","volume":"16","author":"Singer","year":"2005","journal-title":"Anti-Cancer Drug"},{"key":"10.1016\/j.jconrel.2006.10.012_bib6","first-page":"6387","article-title":"A new concept for macromolecular therapies in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumour agent SMANCS","volume":"6","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.10.012_bib7","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents\u2013drug\u2013polymer conjugates","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2006.10.012_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(98)00009-1","article-title":"HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line","volume":"54","author":"Minko","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.10.012_bib9","series-title":"Polymeric Drug Delivery System","first-page":"1","article-title":"N-(2-Hydroxypropyl) methacrylamide copolymer conjugates","author":"Duncan","year":"2005"},{"key":"10.1016\/j.jconrel.2006.10.012_bib10","series-title":"Handbook of Anticancer Drug Development","first-page":"239","article-title":"Polymer\u2013drug conjugates","author":"Duncan","year":"2003"},{"key":"10.1016\/j.jconrel.2006.10.012_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10611860400011901","article-title":"HPMA copolymer\u20131,5-diazaanthraquinone conjugates as promising anticancer therapeutics","volume":"12","author":"Vicent","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2006.10.012_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm1002","article-title":"Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470","volume":"10","author":"Satchi-Fainaro","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2006.10.012_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2006.10.012_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2006.10.012_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after completion of 5\u00a0years adjuvant treatment for breast cancer","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2006.10.012_bib16","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1016\/S0149-2918(02)85158-X","article-title":"Evolving uses of hormonal agents for breast cancer therapy","volume":"24","author":"Cummings","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2006.10.012_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrc1211","article-title":"Aromatase inhibitors for breast cancer: lessons from the laboratory","volume":"3","author":"Johnston","year":"2003","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.jconrel.2006.10.012_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/anie.200462960","article-title":"Polymer therapeutics designed for a combination therapy of hormone-dependent cancer","volume":"44","author":"Vicent","year":"2005","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.jconrel.2006.10.012_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/10611860500383788","article-title":"HPMA copolymer\u2013aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines","volume":"13","author":"Greco","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2006.10.012_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/bc0001544","article-title":"N-(2-Hydroxypropyl)methacrylamide copolymer\u20136-(3-aminopropyl)\u2013ellipticine conjugates, synthesis, characterisation and preliminary in vitro and in vivo studies","volume":"12","author":"Searle","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.10.012_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0076-6879(74)31034-8","article-title":"Isolation of modified liver lysosomes","volume":"31","author":"Trouet","year":"1974","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib22","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/macp.1983.021841005","article-title":"Polymers containing enzymatically degradable bonds: 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] co-polymers to promote efficient degradation by lysosomal-enzymes","volume":"184","author":"Duncan","year":"1983","journal-title":"Makromol. Chem."},{"key":"10.1016\/j.jconrel.2006.10.012_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known to the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1582-4934.2003.tb00225.x","article-title":"Regulation of apoptosis by bcl-2 family proteins","volume":"7","author":"Burlacu","year":"2003","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2006.10.012_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006469627067","article-title":"Change in the expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer","volume":"65","author":"Kenny","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2006.10.012_bib26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1677\/erc.1.01054","article-title":"Workshop on therapeutic resistance in breast cancer: impact of growth factor signaling pathways and implications for future treatment: Consensus Statement","volume":"12","author":"Gee","year":"2005","journal-title":"Endocr.-Relat. Cancer"},{"key":"10.1016\/j.jconrel.2006.10.012_bib27","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/1381612043452613","article-title":"The design and development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta\u00ae)","volume":"10","author":"Molineux","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2006.10.012_bib28","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1200\/jco.2005.23.16_suppl.lba7011","article-title":"Paclitaxel poliglumex (PPX)\/carboplatin vs paclitaxel\/carboplatin for the treatment of PS2 patients with chemotherapy-na\u00efve advanced non-small cell lung cancer (NSCLC): a phase III study","author":"Langer","year":"2005","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib29","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1200\/jco.2005.23.16_suppl.5012","article-title":"Phase II study of paclitaxel poliglumex (PPX)\/carboplatin (C) for 1st line induction and maintenance therapy of Stage III\/IV ovarian or primary peritoneal carcinoma","author":"Herzog","year":"2005","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib30","first-page":"3980","article-title":"Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl)methacrylamide copolymer bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice","volume":"56","author":"Peterson","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.10.012_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2006.10.012_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cells","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2006.10.012_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-2275(20)33898-0","article-title":"Regulation of caveolin and caveolae by cholesterol in MDCK cells","volume":"39","author":"Hailstones","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2006.10.012_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1091\/mbc.10.4.961","article-title":"Extraction of cholesterol with methyl-\u03b2-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles","volume":"10","author":"Rodal","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2006.10.012_bib35","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/sj.onc.1205300","article-title":"Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells","volume":"21","author":"Fiucci","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2006.10.012_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1348-0421.2004.tb03614.x","article-title":"Effects of endocytosis inhibitory drugs on rubella virus entry into VeroE6 cells","volume":"48","author":"Kee","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.05.006","article-title":"Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells","volume":"338","author":"Sun","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2006.10.012_bib38","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysosomotropic agents","volume":"23","author":"De Duve","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2006.10.012_bib39","unstructured":"J. Kopecek, P. Rejmanova, J. Strohalm, K. Ulbrich, B. Rihova, V. Chytry, R. Duncan, J.B. Lloyd, Synthetic polymeric drugs, EU Patent Application 85309560.2, December 31st, 1985."},{"key":"10.1016\/j.jconrel.2006.10.012_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0168-3659(92)90088-9","article-title":"Preclinical evaluation of polymer-bound doxorubicin","volume":"19","author":"Duncan","year":"1992","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.10.012_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-3659(01)00220-6","article-title":"Preliminary evaluation of caspases-dependent apoptosis signalling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells","volume":"71","author":"Minko","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.10.012_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0939-6411(99)00033-8","article-title":"HPMA copolymer-anticancer drug\u2013OV\u2013TL16 antibody conjugates: 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line","volume":"49","author":"Kunath","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2006.10.012_bib43","first-page":"247","article-title":"The effect of HPMA\u2013copolymer-bound doxorubicin conjugates on the expression of genes involved in apoptosis signalling","volume":"91","author":"Kovar","year":"2003","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906005542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906005542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T15:40:10Z","timestamp":1628005210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906005542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0168365906005542"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.10.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}